Secor Capital Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-29,735
Closed -$881K 509
2017
Q1
$881K Buy
+29,735
New +$812K 0.1% 260
2016
Q4
Sell
-43,088
Closed -$972K 536
2016
Q3
$972K Buy
43,088
+4,261
+11% +$100K 0.11% 263
2016
Q2
$925K Buy
38,827
+22,489
+138% +$539K 0.12% 257
2016
Q1
$388K Buy
+16,338
New +$399K 0.05% 379
2015
Q4
Sell
-13,684
Closed -$283K 568
2015
Q3
$283K Buy
+13,684
New +$347K 0.09% 367
2015
Q1
Sell
-8,480
Closed -$202K 480
2014
Q4
$202K Buy
+8,480
New +$188K 0.08% 347
2014
Q3
Sell
-11,702
Closed -$280K 339
2014
Q2
$280K Buy
+11,702
New +$282K 0.15% 206

Other funds holding GMED

Secor Capital Advisors's GMED Position: Q2 2017 in Review

Secor Capital Advisors sold out of Globus Medical (GMED) in Q2 2017, closing a stake of 29,735 shares — an estimated $881K sold.

Secor Capital Advisors first reported a position in GMED in Q2 2014 and held it in 7 quarters. The position peaked at $972K in Q3 2016. 244 funds tracked by Wall St. Rank hold GMED as of Q2 2017.

  • Secor Capital Advisors reported no remaining Globus Medical position as of Q2 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 29,735 Globus Medical shares in Q2 2017, an estimated $881K.
  • Secor Capital Advisors first reported a position in Globus Medical in Q2 2014 and held it in 7 quarters.
  • Secor Capital Advisors's Globus Medical position peaked at $972K in Q3 2016.
  • 244 funds tracked by Wall St. Rank held Globus Medical as of Q2 2017.

Based on Secor Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.